Compare AstraZeneca plc (AZN) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs M&T Bank Corporation — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while M&T Bank Corporation trades at $251.93 (market cap $36.42B). The key difference: AstraZeneca plc is far larger — about 6.8× M&T Bank Corporation's market cap, and M&T Bank Corporation pays the higher dividend (2.38%). Which is the better fit depends on your goals.
| AZN | MTB | |
|---|---|---|
Market Cap | $248.14B | $36.42B |
Sector | Health | Financials |
52-Week High | $209.48 | $254.04 |
52-Week Low | $147.06 | $178.63 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | 2.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
